Educational Intervention for Asthmatic and Allergic Patients

NCT ID: NCT04928638

Last Updated: 2021-06-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-12

Study Completion Date

2021-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Despite its importance, there are few studies that implement the use of new technologies in the approach to patients with asthma and allergy. Therefore, the objective of this study is to evaluate the effectiveness of a telematic educational intervention in patients with allergies and / or asthma

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma Allergy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Virtual educational intervention

Educational intervention about the disease, the use of medication and the context of pandemic

Group Type EXPERIMENTAL

Virtual educational intervention

Intervention Type BEHAVIORAL

Educational intervention about the disease, the use of medication and the context of pandemic

Written educational intervention

Educacional intervention about the disease, the use of medication and the context of pandemic

Group Type EXPERIMENTAL

Written educational intervention

Intervention Type BEHAVIORAL

Educational intervention about the disease, the use of medication and the context of pandemic

Control intervention

Control intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual educational intervention

Educational intervention about the disease, the use of medication and the context of pandemic

Intervention Type BEHAVIORAL

Written educational intervention

Educational intervention about the disease, the use of medication and the context of pandemic

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Asthmatic and allergic patients

Exclusion Criteria

* Cognitive impairment.
* Diagnose of autism spectrum disorder or severe intellectual disability
* Physical or functional impairment that limits the performance of evaluation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad de Granada

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marie Carmen Valenza

Principal Investigator; PT; PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DF0096UG

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Virtual Asthma Clinic
NCT00562081 TERMINATED PHASE4
Asthma in Children
NCT01286532 COMPLETED
Allergy Immunotherapy for the Reduction of Asthma
NCT01028560 COMPLETED PHASE1/PHASE2
The Effect of Education Given to Children With Asthma
NCT06742320 ACTIVE_NOT_RECRUITING NA
ENLaCE Pilot Study
NCT01641211 COMPLETED NA